Daily Stock Analysis, NK, NantKwest Inc, priceseries

NantKwest Inc. Daily Stock Analysis
Stock Information
Open
34.02
Close
33.90
High
34.30
Low
33.64
Previous Close
34.24
Daily Price Gain
-0.34
YTD High
46.82
YTD High Date
May 10, 2021
YTD Low
0.93
YTD Low Date
Dec 26, 2018
YTD Price Change
8.90
YTD Gain
35.60%
52 Week High
46.82
52 Week High Date
May 10, 2021
52 Week Low
29.74
52 Week Low Date
Mar 9, 2021
52 Week Price Change
-9.16
52 Week Gain
-21.27%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 11. 2017
3.18
May 19. 2017
3.54
6 Trading Days
11.16%
Link
LONG
Jun 12. 2017
4.90
Jul 6. 2017
7.26
17 Trading Days
48.09%
Link
LONG
Nov 16. 2017
4.25
Nov 28. 2017
4.55
7 Trading Days
6.97%
Link
LONG
Apr 11. 2018
3.78
Apr 25. 2018
4.02
10 Trading Days
6.32%
Link
LONG
Sep 18. 2018
3.04
Oct 10. 2018
3.61
16 Trading Days
18.74%
Link
LONG
Nov 5. 2018
2.47
Nov 9. 2018
2.83
4 Trading Days
14.78%
Link
LONG
Dec 31. 2018
1.16
Jan 22. 2019
1.28
14 Trading Days
10.06%
Link
LONG
Mar 1. 2019
1.32
Mar 4. 2019
1.49
1 Trading Days
12.87%
Link
LONG
Jul 15. 2019
1.12
Jul 24. 2019
1.22
7 Trading Days
8.67%
Link
LONG
Nov 22. 2019
1.23
Dec 3. 2019
1.35
6 Trading Days
9.96%
Link
LONG
Dec 6. 2019
1.58
Jan 7. 2020
3.52
20 Trading Days
122.82%
Link
LONG
Jan 15. 2020
5.30
Jan 22. 2020
5.81
4 Trading Days
9.67%
Link
LONG
May 6. 2020
4.20
May 15. 2020
4.44
7 Trading Days
5.71%
Link
LONG
Jun 18. 2020
8.15
Jun 26. 2020
9.95
6 Trading Days
22.12%
Link
LONG
Jun 29. 2020
10.82
Jul 23. 2020
13.58
17 Trading Days
25.52%
Link
LONG
Dec 3. 2020
9.20
Dec 16. 2020
10.77
9 Trading Days
17.06%
Link
LONG
Dec 21. 2020
16.02
Dec 24. 2020
17.09
3 Trading Days
6.68%
Link
LONG
Feb 1. 2021
20.18
Feb 23. 2021
33.68
15 Trading Days
66.92%
Link
Company Information
Stock Symbol
NK
Exchange
NasdaqGS
Company URL
http://www.nantkwest.com
Company Phone
(858) 633-0300
CEO
Patrick Soon-Shiong
Headquarters
California
Business Address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001326110
About

NantKwest, Inc. is a next generation clinical-stage immunotherapy company, which engages n the development and production of cancer treatment products. Its products are based on its proprietary natural killer (NK) cell line, NK-92. The firm operates through the following geographical segments: United States; Europe; and Other non-U.S. It also develops cell therapies for renal cell carcinoma and melanoma. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in Culver City, CA.

Description

NantKwest, Inc., a clinical-stage immunotherapy biotechnology company, develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States. The company develops activated natural killer product candidates for the treatment of virally-induced cancers, such as polyoma virus induced merkel cell carcinoma, human papilloma virus induced cervical, and head and neck cancers; infectious diseases, including Ebola; and other serious viral, fungal, and bacterial infections. It is also develops high-affinity natural killer product candidates primarily for the treatment of solid tumors, breast cancer, head and neck/squamous, lymphoma, and various cancer; and target activated natural killer product candidates to treat hematological malignancies and solid tumors. NantKwest, Inc. has a co-development agreement with Altor Bio Science Corporation to collaborate on the development of therapeutic applications combining the company's proprietary natural killer cells with Altor's ALT-801 and/or ALT-803 products. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in San Diego, California.